[Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].

Zhonghua fu chan ke za zhi

Volumn 45, Issue 4, 2010, Pages 247-251

  Long, Qi qi ^a   Zhang, Shao fen ^b   Han, Y ^b   Chen, Hang ^b   Li, Xue lian ^b   Hua, Ke qin ^b   Hu, Wei guo ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; DYDROGESTERONE; ESTRADIOL; ESTRADIOL VALERATE; FOLLITROPIN; GONADORELIN; GOSERELIN; OSTEOCALCIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; DRUG POTENTIATION; ENDOMETRIOSIS; FEMALE; HOSPITALIZATION; HUMAN; MIDDLE AGED; PAIN; PATHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE DENSITY; DRUG ADMINISTRATION SCHEDULE; DYDROGESTERONE; ENDOMETRIOSIS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; MIDDLE AGED; OSTEOCALCIN; PAIN; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955683274     PISSN: 0529567X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)